Document Type : Original Article
Authors
- Atefeh Ramezani 1
- Tahura Etezadi 2
- Hamidreza Goli 3
- Nafas Daraei 4
- Majid Saeedi 5
- Melika Mollaei 4
- Alireza Sedighi 4
- Abolfazl Hosseinnattaj 5
- Hodis Ehsani 6
1 Dept. of Prosthodontics, Dental Research Center, Faculty of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran.
2 Dept. of Orthodontics, Dental Research Center, Faculty of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran.
3 Dept. of Medical Microbiology and Virology, Faculty of Medicine, Mazandaran University of Medical Science, Sari, Iran.
4 Student Dentistry, Dental Research Center, Student Research Committee, Faculty of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran.
5 Pharmaceutical Sciences Research Center, Haemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.
6 Dept. of Biostatistics, Faculty of Health, Mazandaran University of Medical Sciences, Sari, Iran.
Abstract
Background: The emergence of resistance, side effects, and the high cost of drugs indicates a need for other therapeutic alternatives with similar properties but fewer side effects.
Purpose: The present study aims to compare the antimicrobial effect of atorvastatin and nano-atorvastatin mouthwash on Aggregatibacter actinomycetemcomitans.
Materials and Method: In this in vitro study, the atorvastatin and nano-atorvastatin mouthwashes were prepared, and their antibacterial property against Aggregatibacter actinomycetemcomitans was assessed using the agar well diffusion and microbroth dilution tests. Water and chlorhexidine were considered as the negative and positive control groups. Kruskal-Wallis and Mann-Whitney tests were used to compare the size of the diameter of the non-growth halo. Data analysis was obtained using SPSS V.22, and the significance level was considered less than 0.05.
Results: The results of the well diffusion test showed that the diameter of the non-growth halo of chlorhexidine, atorvastatin, and nano-atorvastatin was 27, 18, and 12mm, respectively. The diameter of the halo of non-growth among different substances was statistically significant (p Value=0.08), however, no significant difference was observed between atorvastatin and nano-atorvastatin (p= 0.05). The findings of the microbroth dilution test showed that atorvastatin and nano-atorvastatin had the minimum inhibitory concentration of 0.039 and 0.002 µg/ml, respectively.
Conclusion: The present study suggests strong antimicrobial activity of atorvastatin and nano-atorvastatin against Aggregatibacter actinomycetemcomitans. Therefore, these substances can be used as an additional drug in treating periodontal diseases.
Keywords
- Nazir M, Al-Ansari A, Al-Khalifa K, Alhareky M, Gaffar B, Almas K. Global prevalence of periodontal disease and lack of its surveillance. Sci World J. 2020; 2020: 2146160.
- Bartold PM, Van Dyke TE. An appraisal of the role of specific bacteria in the initial pathogenesis of periodontitis. J Clin Periodontol. 2019; 46: 6-11.
- Łasica A, Golec P, Laskus A, Zalewska M, Gędaj M, Popowska M. Periodontitis: etiology, conventional treatments, and emerging bacteriophage and predatory bacteria therapies. Front Microbiol. 2024; 15: 1469414.
- Klokkevold P, Mealey B, Otomo-Corgel J, Dwarakanath C. Periodontal Treatment of Medically Compromised Patients and Patients With Special Needs. Newman and Carranza's Clinical Periodontology: 4th ed. South Asia Edition-E-Book. 2024. p. 357.
- Kuru BE, Kuka GI, Tunar OL. Role of the mechanical interdental plaque control in the management of periodontal health: How many options do we have? Gingival disease: A professional approach for treatment and prevention. Avilable at: https://www.intechopen.com/chapters/ 63884
- Di*Spirito F, Schiavo L, Pilone V, Lanza A, Sbordone L, D’Ambrosio F. Periodontal and peri-implant diseases and systemically administered statins: A systematic review. Dent J. 2021; 9: 100.
- Vyas T, Bhatt G, Gaur A, Sharma C, Sharma A, Nagi R. Chemical plaque control-A brief review. J Family Med Prim Care. 2021; 10: 1562-1568.
- Jabbareh L, Ehsani H, Goli H, Nattaj AH, Ebadian S, Mollaei M, et al. Comparing the Inhibitory Effect of Kefir Drink and Chlorhexidine Mouthwash against Oral Bacteria in Orthodontic Patients. J Dent (Shiraz). 2025; 26: 171-176.
- Rao N, Pradeep A, Bajaj P, Kumari M, Naik S. Simvastatin local drug delivery in smokers with chronic periodontitis: a randomized controlled clinical trial. Aust Dent J. 2013; 58: 156-162.
- Saewong S, Thammasitboon K, Wattanaroonwong N. Simvastatin induces apoptosis and disruption of the actin cytoskeleton in human dental pulp cells and periodontal ligament fibroblasts. Arch Oral Biol. 2013; 58: 964-974.
- Petit C, Batool F, Bugueno IM, Schwinté P, Benkirane-Jessel N, Huck O. Contribution of statins towards periodontal treatment: a review. Mediators Inflamm. 2019; 2019: 6367402.
- Cicek Ari V, Ilarslan YD, Erman B, Sarkarati B, Tezcan I, Karabulut E, et al. Statins and IL-1β, IL-10, and MPO levels in gingival crevicular fluid: preliminary results. J Inflamm. 2016; 39: 1547-1557.
- Pradeep A, Garg V, Kanoriya D, Singhal S. 1.2% rosuvastatin versus 1.2% atorvastatin gel local drug delivery and redelivery in treatment of intrabony defects in chronic periodontitis: a randomized placebo‐controlled clinical trial. J Periodontol. 2016; 87: 756-762.
- Sreenivasalu PKP, Dora CP, Swami R, Jasthi VC, Shiro-orkar PN, Nagaraja S, et al. Nanomaterials in dentistry: current applications and future scope. Nanomaterials (Basel). 2022;12: 1676.
- Pradeep A, Kumari M, Rao NS, Martande SS, Naik SB. Clinical efficacy of subgingivally delivered 1.2% atorvastatin in chronic periodontitis: a randomized controlled clinical trial. J Periodontol. 2013; 84: 871-879.
- Muniz FWMG, Taminski K, Cavagni J, Celeste RK, Weidlich P, Rösing CK. The effect of statins on periodontal treatment- a systematic review with meta-analyses and meta-regression. Clin Oral Investig. 2018; 22: 671-687.
- Jeger R, Dieterle T. Statins: have we found the Holy Grail? Swiss Med Wkly. 2012; 142(0506): w13515-w.
- Vahabi S, Hakemi-Vala M, Gholami S. In vitro antibacterial effect of hydroalcoholic extract of lawsonia inermis, Malva sylvestris, and Boswellia serrata on Aggregatib-acter actinomycetemcomitans. Adv Biomed Res. 2019; 8: 22.
- Boyanova L, Setchanova L, Gergova G, Kostyanev T, Yordanov D, Popova C, et al. Microbiological diagnosis of the severe chronic periodontitis. J IMAB. 2009; 15: 89 -94.
- Modarres-Gheisari SMM, Gavagsaz-Ghoachani R, Mal-aki M, Safarpour P, Zandi M. Ultrasonic nano-emulsification: A review. Ultrason Sonochem. 2019; 52: 88-105.
- Karimian M, Pourahmadi M, Jelodar G, Mehrabi F, Mo-hammadi Z. The Effect of Atorvastatin on the pancreatic tissue of male rats. Armaghane-danesh. 2013; 18: 5.
- Tajbakhsh M, Saeedi M, Morteza-Semnani K, Akbari J, Nokhodchi A. Innovation of testosome as a green formulation for the transdermal delivery of testosterone enanthate. J Drug Deliv Sci Tech. 2020; 57: 101685.
- Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech. 2010; 11: 1119-1127.
- Kowalska-Krochmal B, Dudek-Wicher R. The minimum inhibitory concentration of antibiotics: Methods, interpretation, clinical relevance. J Pathog. 2021; 10: 165.
- Barnes L, Heithoff DM, Mahan SP, House JK, Mahan MJ. Antimicrobial susceptibility testing to evaluate minimum inhibitory concentration values of clinically relevant antibiotics. STAR Protocols. 2023; 4: 102512.
- Donthi MR, Munnangi SR, Krishna KV, Saha RN, Singhvi G, Dubey SK. Nanoemulgel: a novel nano carrier as a tool for topical drug delivery. J Pharm. 2023; 15: 164.
- Fan W, Duan M, Sun Q, Fan B. Simvastatin enhanced antimicrobial effect of Ag+ against E. faecalis infection of dentine through PLGA codelivery submicron particles. J Biomater Sci Polym Ed. 2020; 31(18): 2331-2346.
- Grover HS, Luthra S, Maroo S, Maroo N. The pleotropic role of statins: Could it be the imminent host modulation agent in periodontics? Dent Res J (Isfahan).2013;10: 143.
- Masadeh M, Mhaidat N, Alzoubi K, Al-Azzam S, Alnas-ser Z. Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin. Ann Clin Microbiol Antimicrob. 2012; 11: 1-5.
- Climent E, Benaiges D, Pedro-Botet J. Hydrophilic or li-pophilic statins? Front Cardiovasc Med. 2021; 8: 687585.
- Bergman P, Linde C, Pütsep K, Pohanka A, Normark S, Henriques-Normark B, et al. Studies on the antibacterial effects of statins- in vitro and in vivo. PLoS One. 2011; 6: e24394.
- Das S, Pudakalkatti PS, Vaz A, Kour P, Padmanabhan S. Determination of the antibacterial activity of atorvastatin against periodontal pathogens, aggregatibacter actinomy-cetemcomitans and Porphyromonas gingivalis: An: in vitro: Study. J Interdiscip Dent. 2020; 10: 3-8.
- Mansouri M, Khayam N, Jamshidifar E, Pourseif T, Kianian S, Mirzaie A, et al. Streptomycin sulfate–loaded niosomes enables increased antimicrobial and anti-biofilm activities. Front bioeng biotechnol. 2021; 9: 745099.
- Hemmati J, Chegini Z, Arabestani MR. Niosomal‐based drug delivery platforms: a promising therapeutic approach to fight staphylococcus aureus drug resistance. J Nano-mater. 2023; 2023: 5298565.
- Jirandehi AK, Asgari R, Shahbaz SK, Rezaei N. Nanom-edicine marvels: crafting the future of cancer therapy with innovative statin nano-formulation strategies. Nanoscale Adv. 2024; 6: 24.
- Emani S, Gunjiganur GV, Mehta DS. Determination of the antibacterial activity of simvastatin against periodont-l pathogens, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans: An: in vitro: study. Contemp Clin Dent. 2014; 5: 377-382.
- Lindy O, Suomalainen K, Mäkelä M, Lindy S. Statin use is associated with fewer periodontal lesions: A retrospective study. BMC Oral Health. 2008; 8: 1-7.
- Kadkhoda Z, Amarlu Z, Eshraghi S, Samiei N. Antimicrobial effect of chlorhexidine on Aggregatibacter actinom-ycetemcomitans biofilms associated with peri-implantitis. J Dent Res Dent. 2016; 10: 176.
)